Tenaya Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
COLUMN GROUP LLC | 11/14/2024 | 9.40 M | $18.14 M | 0.00% | 10.91% |
RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 6.98 M | $13.48 M | -8.39% | 8.10% |
CASDIN CAPITAL, LLC | 11/14/2024 | 6.73 M | $12.99 M | 0.00% | 7.81% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 4.11 M | $7.93 M | 100.00% | 4.77% |
VANGUARD GROUP INC | 11/13/2024 | 3.21 M | $6.20 M | 1.55% | 3.73% |
PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 3.03 M | $5.85 M | -13.81% | 3.51% |
OCTAGON CAPITAL ADVISORS LP | 11/14/2024 | 2.58 M | $4.97 M | 0.00% | 2.99% |
INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2024 | 2.38 M | $4.58 M | 2.15% | 2.76% |
CITADEL ADVISORS LLC | 11/14/2024 | 2.34 M | $4.51 M | 8.96% | 2.71% |
VR ADVISER, LLC | 11/14/2024 | 1.56 M | $3.00 M | 0.00% | 1.81% |
GHOST TREE CAPITAL, LLC | 11/14/2024 | 1.50 M | $2.90 M | 11.11% | 1.74% |
FMR LLC | 11/13/2024 | 1.35 M | $2.60 M | 1.93% | 1.56% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.30 M | $2.50 M | 5.45% | 1.50% |
STATE STREET CORP | 11/14/2024 | 1.06 M | $2.04 M | 0.91% | 1.23% |
EUCLIDEAN CAPITAL LLC | 11/14/2024 | 1.02 M | $1.96 M | 0.00% | 1.18% |
SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 917,370 | $1.77 M | 156.61% | 1.06% |
ALPHABET INC. | 11/08/2024 | 915,705 | $1.77 M | 0.00% | 1.06% |
ABRDN PLC | 10/25/2024 | 550,700 | $1.06 M | 100.00% | 0.64% |
STEPSTONE GROUP LP | 11/12/2024 | 462,163 | $891.98 M | 0.00% | 0.54% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 380,468 | $734,303 | 141.63% | 0.44% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 337,265 | $650,921 | 204.39% | 0.39% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 328,675 | $634,343 | 17.11% | 0.38% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 324,245 | $625,793 | -67.58% | 0.38% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 315,802 | $609,498 | 43.56% | 0.37% |
MORGAN STANLEY | 11/14/2024 | 312,991 | $604,073 | 76.11% | 0.36% |
WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 294,133 | $567,677 | 35.61% | 0.34% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 275,815 | $532,322 | 0.00% | 0.32% |
BARCLAYS PLC | 11/19/2024 | 269,464 | $520,000 | -1.47% | 0.31% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 235,500 | $454,515 | 40.18% | 0.27% |
SQUAREPOINT OPS LLC | 11/14/2024 | 206,416 | $398,383 | 71.01% | 0.24% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 202,044 | $389,944 | -14.96% | 0.23% |
NEOS INVESTMENT MANAGEMENT LLC | 11/13/2024 | 169,127 | $326,415 | 8.36% | 0.20% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 158,416 | $305,744 | 26.04% | 0.18% |
MARSHALL WACE, LLP | 11/14/2024 | 158,057 | $305,050 | 100.00% | 0.18% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 152,588 | $294,495 | 0.00% | 0.18% |
GSA CAPITAL PARTNERS LLP | 11/05/2024 | 147,932 | $286,000 | -18.75% | 0.17% |
PANAGORA ASSET MANAGEMENT INC | 11/13/2024 | 130,524 | $251,911 | 147.47% | 0.15% |
D. E. SHAW & CO., INC. | 11/14/2024 | 126,497 | $244,139 | 100.00% | 0.15% |
AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 120,009 | $231,617 | 17.52% | 0.14% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 114,232 | $220,467 | 11.96% | 0.13% |
RHUMBLINE ADVISERS | 11/12/2024 | 79,599 | $153,615 | 1.84% | 0.09% |
TWO SIGMA ADVISERS, LP | 11/14/2024 | 76,400 | $147,452 | -4.50% | 0.09% |
WALLEYE CAPITAL LLC | 11/14/2024 | 69,479 | $134,094 | 100.00% | 0.08% |
HIGHPOINT ADVISOR GROUP LLC | 11/04/2024 | 68,890 | $133,647 | 0.00% | 0.08% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 54,714 | $105,598 | -49.14% | 0.06% |
ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 49,570 | $95,670 | 0.00% | 0.06% |
XTX TOPCO LTD | 11/14/2024 | 49,290 | $95,130 | 51.18% | 0.06% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2024 | 49,094 | $94,752 | 100.00% | 0.06% |
ALGERT GLOBAL LLC | 11/12/2024 | 33,030 | $64,000 | 38.57% | 0.04% |
JANE STREET GROUP, LLC | 11/15/2024 | 30,806 | $59,456 | -52.08% | 0.04% |
Tenaya Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 107 institutional investors and hedge funds held shares of Tenaya Therapeutics, Inc.. The most heavily invested institutionals were:
Column Group LLC: 9.4 M
RA CAPITAL MANAGEMENT, L.P.: 6.98 M
Casdin Capital, LLC: 6.73 M
BlackRock Funding, Inc. /DE: 4.11 M
VANGUARD GROUP INC: 3.21 M
PRICE T ROWE ASSOCIATES INC /MD/: 3.03 M
66.89% of Tenaya Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 61.47 M shares in the last 24 months. This purchase volume represents approximately $92.82 M in transactions.